Pulmonary Embolism Market Expansion Outlook: $3.62 Billion by 2029 Forecast

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Pulmonary Embolism Market Between 2025 And 2029?

The pulmonary embolism market has experienced rapid expansion in recent years. This market is projected to expand from $2.03 billion in 2024 to reach $2.26 billion by 2025, driven by a compound annual growth rate (CAGR) of 11.4%. Historically, this growth can be linked to factors such as anticoagulant therapies, extensive research and clinical trials, heightened pulmonary embolism awareness, and effective VTE prophylaxis strategies.

The pulmonary embolism market size is projected to experience substantial expansion in the coming years. It is anticipated to reach $3.62 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.5%. This anticipated growth during the forecast period is due to factors such as targeted therapies, telemedicine and remote monitoring, health equity initiatives, and global health initiatives. Key developments expected over the forecast period encompass artificial intelligence in diagnosis, novel anticoagulants, pulmonary embolism response teams, and patient-centered care.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13026&type=smp

What Are The Top Growth Drivers Impacting The Pulmonary Embolism Market Outlook?

The rising occurrence of blood clots is projected to fuel expansion in the pulmonary embolism market in the coming years. A blood clot, also referred to as a thrombus, is a semisolid or gel-like mass that develops inside a blood vessel. These clots elevate the likelihood of pulmonary embolism by hindering blood circulation to the lungs. Such blockages, frequently forming in the deep veins of the legs, consequently heighten the risk of pulmonary embolism. Illustratively, an article from April 2022, released by Gavi, the Vaccine Alliance, an international body dedicated to enhancing access to novel and underutilized vaccines for children, reported that within 30 days post-COVID-19 exposure, researchers observed a 33-fold surge in the probability of potentially lethal clots in the lungs and a five-fold increase in the danger of deep vein thrombosis. Consequently, the growing prevalence of blood clots is a key factor propelling the growth of the pulmonary embolism market.

What Are The Different Segment Classifications Within The Pulmonary Embolism Market?

The pulmonary embolismmarket covered in this report is segmented –

1) By Treatment: Medications; Mechanical Devices; Other Treatments

2) By Diagnosis: Chest X-Ray; Electrocardiogram (ECG); Magnetic Resonance Imaging (MRI); Computed Tomography Scan; Pulmonary Angiography; Venography; Venous Ultrasound; D-Dimer Test; Other Diagnosis

3) By Symptoms: Shortness Of Breath; Chest Pain; Cough; Irregular Heartbeat; Dizziness; Fever; Cyanosis; Other Symptoms

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels

5) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users

Subsegments:

1) By Medications: Anticoagulants; Thrombolytics

2) By Mechanical Devices: Inferior Vena Cava (IVC) Filters; Catheter-Assisted Thrombectomy

3) By Other Treatments: Surgical Embolectomy; Supportive Care

What Are The Major Trends Driving The Growth Of The Pulmonary Embolism Market?

Major companies within the pulmonary embolism market are actively focusing on developing innovative products like the Triever16 Curve catheter and the RevCore thrombectomy catheter to secure a competitive edge. For instance, in June 2023, Inari Medical Inc., a US-based medical device company, launched both the Triever16 Curve catheter and the RevCore thrombectomy catheter. This advanced Triever16 Curve catheter is specifically engineered for peripheral thrombectomy and pulmonary embolism procedures, boasting high trackability and a pre-shaped curve for focused aspiration. Its unique design also permits easy access for larger and more powerful 20F or 24F catheters. The RevCore thrombectomy catheter is designed to treat venous in-stent thrombosis and functions as a mechanical thrombectomy device utilizing a nitinol basket to capture and remove blood clots. Furthermore, these catheters enhance the safety and effectiveness of pulmonary embolism procedures.

Which Global Market Leaders Are Shaping The Future Of The Pulmonary Embolism Sector?

Major companies operating in the pulmonary embolism market are Pfizer Inc., Johnson and Johnson Private Limited, F. Hoffmann-La Roche Ltd., Merck And Co.Inc., Novartis AG, Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, GSK PLC, Abbott Laboratories, AstraZeneca PLC, Medtronic PLC, Eli Lilly and Company, Gilead Sciences Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Mitsubishi Tanabe Pharma Corporation, Genentech Inc., Hikma Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Nippon Shinyaku Co. Ltd., Penumbra Inc., Fresenius Kabi AG, Inari Medical Inc., AngioDynamics Inc., Otsuka Pharmaceutical Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Pulmonary Embolism Market?

North America was the largest region in the pulmonary embolism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pulmonary embolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Pulmonary Embolism Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13026&type=smp

Browse Through More Reports Similar to the Global Pulmonary Embolism Market 2025, By The Business Research Company

Cardiac Assist Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Cardiac Pacemakers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795